Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia
FetalEase Ltd. · NCT05913609
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 4
- Study start
- November 15, 2023
- Record last updated
- November 25, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.
Being studied: Yaari Extractor
Conditions: Shoulder Dystocia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Subject 18 years of age or older at time of consent.
- Subject planning on vaginal birth.
- Singleton pregnancy in vertex presentation.
- Full-term pregnancy having completed 37 weeks or more gestational weeks.
- Able and willing to provide written informed consent prior to enrollment.
- In the opinion of the Investigator, the subject has sufficient mental capacity to understand the informed consent form (ICF).
- Subject with fetus experiencing shoulder dystocia as defined by ACOG Practice Bulletin 178 "Shoulder dystocia is most commonly diagnosed as failure to deliver the fetal shoulder(s) with gentle downward traction on the fetal head, requiring additional maneuvers to effect delivery."
Exclusion Criteria
- Patients who have undergone attempted delivery using ancillary standard of care maneuvers, to include first-line maneuvers (McRoberts ± suprapubic pressure with downward traction on the fetal head), prior to use of the Yaari Extractor. (NOTE: Hyperflexion of the hips or legs is allowed prior to and during use of the Yaari Extractor.)
- Cesarean section is planned for the patient.
- Obstetric contraindications to vaginal birth.
- Subject carrying fetus with known significant chromosomal or structural anomalies.
- Clinically estimated fetal weight ≥5kg in non-diabetic subjects.
- Clinically estimated fetal weight ≥4.5kg in subjects with diabetes.
- Subject has any general health condition or systemic disease that may represent, in the opinion of the Investigator, a potential increased risk associated with device use or pregnancy.
- Bleeding disorders, such as thrombocytopenia, von Willebrand's disease, bleeding disorder currently using anticoagulation medication, etc.
- Any maternal disease or disorder that precludes the subject from pushing effectively.
- If the maternal cervix is not fully dilated.
- If the fetal head is not completely out of the birth canal.
- In the presence of a non-reducible nuchal cord.
Recruiting US locations
University of Miami - Jackson Memorial
Miami, FL 33136
Site contact: Jemima Duroseau, BSN, RN, MPH · 305-689-8010 · jxp431@med.miami.edu
Rosemark WomenCare Specialist
Idaho Falls, ID 83404
Site contact: Nora Ramirez · 208-557-2924 · nramirez@rosemark.net
Unified Women's Clinical Research
Winston-Salem, NC 27103
Site contact: Nicole Cline · 336-955-8065 · nicole.cline@unifiedhc.com
Inova Fairfax Medical Campus
Falls Church, VA 22042
Site contact: Fatima Sahar, MBBS · 703-776-4600 · Sahar.Fatima@inova.org
Study contacts (from the official record)
- Ahava Stein · +972522346927 · ahava@asteinrac.com
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65